Mark Wallace is dean of the graduate school at Vanderbilt University in Nashville, Tennessee.
Mark Wallace
Director of the Vanderbilt Brain Institute
From this contributor
We need precise measurements of sensory traits related to autism
Separating sensitivity to sensory stimuli from the response to the stimuli may help scientists understand the root cause of sensory traits in autistic people.
We need precise measurements of sensory traits related to autism
By
Mark Wallace
30 July 2019 | 5 min read
Timing is key to understanding sensory, social issues in autism
Individuals with autism have trouble reading social cues because their brains connect sights and sounds over unusually long periods of time.
Timing is key to understanding sensory, social issues in autism
By
Mark Wallace
9 August 2016 | 8 min read
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
By
Amber Dance
18 September 2026 | 9 min read
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
By
Brendan Borrell
17 September 2026 | 4 min read
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 1 min read